Australia's Mayne Pharma falls as treasurer considers blocking Cosette's $437 million bid

Core Viewpoint - Mayne Pharma has received a letter from potential acquirer Cosette, indicating that the Australian treasurer is considering blocking the acquisition valued at A$672 million (approximately $436.67 million) [1] Group 1 - Mayne Pharma is in the process of being acquired by Cosette [1] - The acquisition deal is valued at A$672 million (approximately $436.67 million) [1] - The Australian treasurer's consideration to block the acquisition could impact the deal's completion [1]